Furthermore, the GEPIA database demonstrated that MBOAT2 overexpression was connected to a worse prognosis in pancreatic adenocarcinoma, mesothelioma, uveal melanoma, urothelial carcinoma, and adrenocortical carcinoma but was associated with longer survival in kidney renal clear cell carcinoma (Figure 4). This evidence concerns the gene MBOAT2 and urothelial carcinoma.